Plasmablastic Lymphoma in Epstein–Barr Virus-negative Patient

Author:

AlSahari Ghaidaa R.1,Al-Marzouki Adel F.23,Bakhsh Salwa I. A.4,Albaity Bushra Shehabaddin5,Hamad Rahf Essam5

Affiliation:

1. Department of Hematology, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia

2. Department of Hematology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

3. King Fahd Medical Research Center, Hematology Research Unit, King Abdulaziz University, Jeddah, Saudi Arabia

4. Department of Pathology, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia

5. Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Abstract

Plasmablastic lymphoma is a rare and aggressive variant of diffuse large B-cell lymphoma. It often develops in immunocompromised patients, particularly in human immunodeficiency virus-positive individuals. This report highlights the development of such a rare, aggressive malignancy in an immunocompetent adult male with negative Epstein–Barr virus serology. The patient was diagnosed 6 months after the onset of neck and submandibular swelling. A pan-computed tomography scan revealed nodal and extranodal involvement of the iliac bone and iliacus muscle. Chemotherapy was planned, but the patient’s condition deteriorated and he died. This case helps us to understand the clinicopathological features of this malignancy in the Saudi population and may help in early detection and better prognosis.

Publisher

Medknow

Reference14 articles.

1. Atypical presentation of plasmablastic lymphoma in immunocompetent patient;Khan;BMJ Case Rep,2021

2. Plasmablastic lymphoma in an immunocompetent patient: A case report and literature review;AlSheef;Cureus,2022

3. Plasmablastic lymphoma: An update;Bailly;Int J Lab Hematol,2022

4. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use;Vaughan;HIV Med,2021

5. The biology and treatment of plasmablastic lymphoma;Castillo;Blood,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3